Application and Value of FFPE Tissue Microarrays in Tumor Marker Screening

Technical Basis of FFPE Tissue Microarrays

FFPE tissue microarrays are a technology in which formalin-fixed, paraffin-embedded tissue samples are rearranged in an array format within a single recipient paraffin block. Compared with conventional single slides, they enable simultaneous detection of dozens to hundreds of tissue cases in a single experiment, reducing reagent consumption and batch-to-batch variation. This technology is compatible with immunohistochemistry, in situ hybridization, and some molecular pathology detection methods, and is particularly suitable for retrospective cohort studies that utilize existing FFPE sample resources.

Advantages in Tumor Marker Screening

The expression distribution of candidate tumor marker proteins or nucleic acids in tissues often needs to be observed in a relatively large sample size. FFPE tissue microarrays can integrate dispersed donor paraffin blocks into a standardized array, facilitating comparison of expression differences among different pathological grades, stages, and histological subtypes. Common designs include tumor tissue spot arrays and paired adjacent non-tumor tissue spot arrays, and some also include normal tissue or benign lesions as references. Performing multi-marker detection on the same microarray can reduce inter-slide operational errors and improve comparability between data sets.

Translational Pathway from Screening to Validation

In the initial screening stage, tissue microarrays containing a relatively large number of sample spots are usually used to observe the expression trends of candidate markers, recording positive localization, intensity, and distribution characteristics. Subsequently, validation can be performed in an independent cohort or an expanded sample set, combined with analysis of clinicopathological parameters. It should be noted that FFPE tissue microarrays reflect the tissue expression status of specific regions; for tumors with strong heterogeneity, multi-point sampling or review in combination with whole-tissue sections may be required. Researchers generally establish unified interpretation rules based on antibody performance, staining conditions, and scoring criteria to reduce subjective bias.

Common Considerations in Applications

When using FFPE tissue microarrays, attention should be paid to factors such as tissue fixation time, microarray spot diameter, section thickness, and antigen retrieval method. Insufficient or excessive fixation may affect antigen detection results, and tissue displacement during microarray preparation also needs to be identified through quality control steps. For low-abundance markers, it is recommended to first perform preliminary experiments with an antibody concentration gradient and to evaluate staining specificity using known positive and negative control tissues. Overall, this technology is more suitable as a medium- to high-throughput screening and retrospective research tool, and its conclusions need to be combined with validation by other methodological approaches.